Login
$NNDM
$1.35 +$0.00 (0.0%) Pre-market

Consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q4 FY2017
As of Dec 31, 2017
Cash and cash equivalents
Total cash and cash equivalents
Bank deposits
Total bank deposits
Restricted deposits
Total restricted deposits
Trade receivables
Total trade receivables
Other receivables
Total other receivables
Inventory
Total inventory
Current assets
Total current assets
Investment in securities
Property plant and equipment, net
Total property plant and equipment, net
Right-of-use assets
Intangible assets
Total intangible assets
Non-current assets
Total non-current assets
Assets
Total assets
Trade payables
Total trade payables
Other payables
Total other payables
Current portion of other long-term liability
Current portion of lease liability
Current portion of bank loan
Current liabilities
Total current liabilities
Liability in respect of government grants
Total liability in respect of government grants
Employee benefits
Lease liability
Deferred tax liabilities
Loan from banks
Total loan from banks
Bank loan
Non-current liabilities
Total non-current liabilities
Liabilities
Total liabilities
Non-controlling interests
Share capital
Total share capital
Share premium and capital reserves
Total share premium and capital reserves
Treasury shares
Total treasury shares
Foreign currency translation reserve
Remeasurement of net defined benefit liability (IAS 19)
Accumulated loss
Total accumulated loss
Equity attributable to owners of the Company
Equity
Total equity
Assets
Current assets:
Cash and cash equivalents
Bank deposits
Marketable equity securities
Restricted bank deposits
Trade receivables, net of allowance for doubtful accounts ($950 and $861, respectively)
Inventory
Other current assets
Total current assets
Restricted bank deposits
Marketable equity securities
Property, plant and equipment, net
Operating lease right-of-use assets
Deferred tax assets
Goodwill
Intangible assets, net
Other assets
Total assets
Liabilities and Equity
Current liabilities:
Trade payables
Accrued liabilities
Deferred Revenue
Current portion of lease liability
Current portion of bank loan
Total current liabilities
Employee benefits
Operating lease right-of-use liabilities
Bank loan
Long-term settlement payable
Long-term deferred revenue
Total liabilities
Non-controlling interests
Equity:
Share capital of NIS 5 par value each; 500,000,000 ordinary shares authorized; 210,589,406 and 206,811,875 shares outstanding as of June 30, 2026 and December 31, 2025, respectively, and 283,084,053 and 279,306,522 shares issued as of June 30, 2026 and December 31, 2025, respectively.
Additional paid-in capital
Treasury stock
Accumulated other comprehensive income
Accumulated Loss
Total equity attributable to common shareholders
Total equity
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support